SPY424.31+0.70 0.17%
DIA345.12+0.14 0.04%
IXIC14,069.42+49.09 0.35%

BRIEF-Stoke Therapeutics Reports Net Loss Of $0.46/Share For Quarter Ended March 31

05/10/2021 07:59
BRIEF-Stoke Therapeutics Reports Net Loss Of $0.46/Share For Quarter Ended March 31

- Stoke Therapeutics Inc STOK.O:

  • STOKE THERAPEUTICS - AS OF MARCH 31, 2021, HAS $267.7 MILLION IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH, ANTICIPATED TO FUND OPERATIONS INTO 2024

  • NET LOSS FOR THE QUARTER ENDED MARCH 31, 2021 WAS $16.8 MILLION, OR $0.46 PER SHARE

  • Q1 EARNINGS PER SHARE VIEW $-0.44 -- REFINITIV IBES DATA

Source text: [https://bit.ly/3tArkqc]

Further company coverage: STOK.O


(([email protected];))